Fannin
Dev Chatterjee is an accomplished professional in the field of biomedical technology and research, serving as Managing Director and Principal at Fannin Innovation Studio since October 2013, where the focus is on biomedical technology commercialization. As Chief Scientific Officer and Co-Founder of BreviTest Technologies, LLC, Dev is involved in developing point-of-care diagnostic technologies. Dev has a rich background in editorial work as an Associate Editor for the American Journal of Cancer Therapy and Pharmacology, and prior research experience includes a Postdoctoral Research Fellowship at M D Anderson Cancer Center, with notable projects at the National University of Singapore and a founder role at Caveat Pte Ltd. Dev holds a Ph.D. in Bioengineering from the National University of Singapore, a Master's in Biomedical Engineering from the Indian Institute of Technology, Kharagpur, and an MBBS from Medical College, Calcutta.
This person is not in any teams
Fannin
Fannin is an early-stage life sciences development group focused on commercializing innovation developed in the Texas Medical Center institutions. Led by an experienced team of managers with diverse business backgrounds, commercialization experience, and strong entrepreneurial knowhow, Fannin partners with promising life science innovators to co-found and actively manage startup companies. Fannin provides its startups with central office space, seed capital and a vast network of resources. To address the root cause of Houston’s commercialization gap, Fannin works directly with the city’s top-tier, higher education institutions to recruit aspiring entrepreneurs to join its apprenticeship program which provides on-the-job training to collaboratively lead its portfolio companies from innovation to commercialization. Future Outlook: Fannin has successfully validated this business model over the last seven years and is now in the process of scaling it up. Another 15-20 portfolio companies are expected to be developed in the next 3 - 5 years. For more information, email innovate@fannininnovation.com.